Skip to main content
Premium Trial:

Request an Annual Quote

Pathology Firm Paige Gets Microsoft Investment for Cloud-Based AI Dx

NEW YORK – Computational pathology firm Paige said Wednesday Microsoft will invest in the company toward development of artificial intelligence-based diagnostics and partner with Paige on cloud-based patient care.

New York City-based Paige said it will partner with Microsoft to use AI-based analysis of digital pathology images to create a "new generation of clinical applications and computational biomarkers to transform cancer diagnosis and patient care." It said Microsoft will also invest in Paige to accelerate development and deployment of those diagnostics as well as partner with Paige on cloud-based delivery of the Paige Platform, which includes digital pathology data management and the firm's FullFocus whole-slide image viewer.

Paige said that it will also work with other entities, including Microsoft Research, to develop large-scale machine learning models for oncology and pathology research. Paige is also working with Nuance, a Microsoft company, to integrate its offering with Nuance's Precision Imaging Network.

Financial terms of the investment agreement remain under negotiation and will be disclosed in the next few months, Paige said through a spokesperson.

Under the agreement, Paige will use Microsoft Azure as its cloud provider and become a Microsoft Cloud for Healthcare partner, which will make Paige's digital cancer diagnostic tools available to Microsoft's healthcare customers.

In September 2021, Paige secured the first US Food and Drug Administration de novo marketing authorization for an AI-based pathology product, the Paige Prostate software to aid in preliminary diagnosis of prostate cancer, and the firm said in May 2022 it had gained CE-IVD and UK Conformity Assessed marks for the tests. The firm said in June 2022 it gained CE-IVD and UKCA marking for its HER2Complete breast cancer biomarker detection software.

In the past year, Paige has also locked up a distribution agreement for its digital pathology software platform with Mindpeak's BreastIHC tool for breast cancer analysis and a partnership with Sonora Quest Laboratory sites in Arizona on custom installations of Paige's digital pathology software.